Results 231 to 240 of about 12,522 (293)

WS10.6 Organ-specific CFTR dysfunction: Comparison of biomarkers for CF diagnosis and CFTR modulator effects

, 2013
L. Pinders-Kessel, S. Scheinert, M. Klosinski, Doris Staab, Nico Derichs   +4 more
openalex   +1 more source

Strength-Oriented Virtual Exercise Training Intervention in Children and Adolescents with Cystic Fibrosis Under CFTR Modulators (the FIQMODE Study): Study Protocol for a Randomized Controlled Trial. [PDF]

Curr Protoc
Pantoja-Arévalo L, Yvert T, Iturriaga T, Sanz-Santiago V, Barceló O, Quesada-González C, Morales-Tirado A, Santiago-Dorrego C, López-Neyra A, Ruiz de Valbuena M, De Manuel Gómez C, Rubio Alonso M, De Vidania S, Ramírez-Castillejo C, González-Gross M, Pérez-Ruiz M.   +15 more
europepmc   +1 more source

Second-Hand Cigarette Smoke Impairs Bacterial Phagocytosis in Macrophages by Modulating CFTR Dependent Lipid-Rafts

, 2015
Inzer Ni, Chang Hoon Ji, Neeraj Vij
openalex   +2 more sources

Efficacy and safety of CFTR modulators in patients with interstitial lung disease caused by ABCA3 transporter deficiency. [PDF]

ERJ Open Res
Le Brun M, Nathan N, Louvrier C, Legendre M, Feuillet S, Frija-Masson J, Onanga M, Morer L, Debray MP, Fajac I, Burgel PR, Marchand-Adam S, Crestani B, Borie R.   +13 more
europepmc   +1 more source

Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant. [PDF]

ERJ Open Res
Yaacoby-Bianu K, Heching M, Kramer MR, Shmueli E, Prais D, Vermeulen F, Ramalho AS, Cohen R, Livnat G, Shteinberg M.   +9 more
europepmc   +1 more source

Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy [PDF]

Pierre‐Régis Burgel, Manfred Ballmann, Pavel Dřevı́nek, Harry Heijerman, Andreas Jung, Jochen G. Mainz, D. Peckham, Barry J. Plant, C. Schwarz, Giovanni Taccetti, Alan R Smyth   +10 more
openalex   +1 more source

Clinical Outcomes in Patients with Cystic Fibrosis Receiving CFTR Modulators: A Comparison of Childhood Versus Adolescent Initiation. [PDF]

Children (Basel)
Toraih EA, Malik HA, Islam RK, Pirzadah HA, Abdelmaksoud A, Elshazli RM, Boasiako PA, Alenazi SA, Dabel A, Jishu JA, Alenezi BT, Aiash H, Fawzy MS.   +12 more
europepmc   +1 more source

Molecular Prostheticsand CFTR Modulators AdditivelyIncrease Secretory HCO₃^– Flux in CysticFibrosis Airway Epithelia

Nohemy Celis (22462516), Danforth P. Miller (22462519), Thomas E. Tarara (22462522), Jeffry G. Weers (22462525), Ian M. Thornell (8909801), Michael J. Welsh (22462528), Martin D. Burke (1280013)   +6 more
openalex   +1 more source

New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient

, 2015
Susanna A. McColley, Jane C. Davies, Félix Ratjen, Manu Jain   +3 more
openalex   +1 more source

Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. [PDF]

J Fungi (Basel)
Chatterjee P, Moss CT, Omar S, Dhillon E, Hernandez Borges CD, Tang AC, Stevens DA, Hsu JL.   +7 more
europepmc   +1 more source